Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice

J Biol Chem. 2023 Feb;299(2):102845. doi: 10.1016/j.jbc.2022.102845. Epub 2022 Dec 28.

Abstract

Obesity and diabetes normally cause mitochondrial dysfunction and hepatic lipid accumulation, while fatty acid synthesis is suppressed and malonyl-CoA is depleted in the liver of severe obese or diabetic animals. Therefore, a negative regulatory mechanism might work for the control of mitochondrial fatty acid metabolism that is independent of malonyl-CoA in the diabetic animals. As mitochondrial β-oxidation is controlled by the acetyl-CoA/CoA ratio, and the acetyl-CoA generated in peroxisomal β-oxidation could be transported into mitochondria via carnitine shuttles, we hypothesize that peroxisomal β-oxidation might play a role in regulating mitochondrial fatty acid oxidation and inducing hepatic steatosis under the condition of obesity or diabetes. This study reveals a novel mechanism by which peroxisomal β-oxidation controls mitochondrial fatty acid oxidation in diabetic animals. We determined that excessive oxidation of fatty acids by peroxisomes generates considerable acetyl-carnitine in the liver of diabetic mice, which significantly elevates the mitochondrial acetyl-CoA/CoA ratio and causes feedback suppression of mitochondrial β-oxidation. Additionally, we found that specific suppression of peroxisomal β-oxidation enhances mitochondrial fatty acid oxidation by reducing acetyl-carnitine formation in the liver of obese mice. In conclusion, we suggest that induction of peroxisomal fatty acid oxidation serves as a mechanism for diabetes-induced hepatic lipid accumulation. Targeting peroxisomal β-oxidation might be a promising pathway in improving hepatic steatosis and insulin resistance as induced by obesity or diabetes.

Keywords: acetyl-carnitine; fatty acid oxidation; mitochondria; obesity; peroxisomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyl Coenzyme A / metabolism
  • Acetylcarnitine / metabolism
  • Animals
  • Diabetes Mellitus, Experimental* / metabolism
  • Fatty Acids / metabolism
  • Fatty Liver* / metabolism
  • Insulin Resistance*
  • Liver / metabolism
  • Malonyl Coenzyme A / metabolism
  • Mice
  • Mice, Obese
  • Obesity / metabolism
  • Oxidation-Reduction

Substances

  • Acetyl Coenzyme A
  • Fatty Acids
  • Malonyl Coenzyme A
  • Acetylcarnitine